The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease

Paul A. Agius, Julia C. Cutts, Peige Song, Igor Rudan, Diana Rudan, Victor Aboyans, Mary M. McDermott, Michael H. Criqui, F. Gerald R. Fowkes, Freya J.I. Fowkes*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

An epidemiological transition in the prevalence of peripheral artery disease (PAD) is taking place especially in low- and middle-income countries (LMICs) where an ageing population and adoption of western lifestyles are associated with an increase in PAD. We discuss the limited evidence which suggests that infection, potentially mediated by inflammation, may be a risk factor for PAD, and show by means of an ecological analysis that country-level prevalence of the major endemic infections of HIV, tuberculosis and malaria are associated with the prevalence of PAD. While further research is required, we propose that scientists and health authorities pay more attention to the interplay between communicable and non-communicable diseases, and we suggest that limiting the occurrence of endemic infections might have some effect on slowing the epidemiological transition in PAD.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalJournal of Epidemiology and Global Health
Volume12
Issue number3
DOIs
StatePublished - Sep 2022

Funding

The Peripheral Arterial Disease Research Coalition (Europe) provided funds for data acquisition and analysis. This work was supported by the National Health and Medical Research Council of Australia (NHMRC) (fellowship to FJIF) and its Independent Research Institute Infrastructure Support Scheme. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funding sources had no role in the writing of the manuscript or the decision to submit for publication. In the past three years, MMM has received research funding from Regeneron and Helixmith and other research support from Mars, Hershey, ReserveAge, Chromadex, and ArtAssist. VA has received payment from Bayer Healthcare, NovoNordisk, AstraZeneca, BoehringerIngelheim. Other authors declare no competing interests.

Keywords

  • Epidemiology
  • HIV
  • Malaria
  • Peripheral arterial disease
  • Tuberculosis

ASJC Scopus subject areas

  • Epidemiology

Fingerprint

Dive into the research topics of 'The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease'. Together they form a unique fingerprint.

Cite this